Last update 2 October 2023
Immunomodulators for non-malignant disease — Parenteral > General injections > IV: 5 mg per mL in 1 mL vial
Oral > Liquid: 0.2 mg granules for oral suspension; 1 mg granules for oral suspension
Oral > Solid: 0.5 mg (immediate-release); 0.75 mg (immediate-release); 1 mg (immediate-release); 2 mg (immediate-release); 5 mg (immediate-release) — Failure or rejection of transplanted organs or tissues — L04AD02 — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
